Business
Mello investor conference
Mello investor conference.
About this update from Inspiration Healthcare Group Plc
[{"type":"text","content":"\n\n 17 May 2023\nInspiration Healthcare Group plc\n(\"Inspiration Healthcare\", the \"Company\" or the \"Group\")\n \nMello investor conference\n \nInspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces that they will be attending the Mello2023 investor conference on Wednesday, 24 May. The conference will take place at the Clayton Hotel Chiswick, Chiswick High Road, London, W4 5RY.\n \nNeil Campbell, CEO of Inspiration Healthcare Group plc will be presenting on the day. The Company will also have an exhibition stand, giving investors the opportunity for discussions with the management.\n \nInvestors wishing to attend can find more details at www.melloevents.com.\n \nFor further information:\n \n\n\n\nInspiration Healthcare Group plc\n\n\nTel: +44 (0)330 175 0000\n \n\n\n\n\nNeil Campbell, Chief Executive Officer\n\n\n\n\n\n\n\nPaul Bergin, Interim Chief Financial Officer\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\nCenkos Securities plc (Nominated Adviser & Broker)\n\n\nTel: +44 (0)207 397 8900\n\n\n\n\nStephen Keys, Katy Birkin, Dan Hodkinson\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWalbrook PR Ltd (Media and Investor Relations)\n\n\nTel: +44 (0)20 7933 8780 or [email protected]\n\n\n\n\nAnna Dunphy\n\n\nMob: +44 (0) 7876 741 001\n\n\n\n\nStephanie Cuthbert\n\n\nMob: +44 (0) 7796 794 663\n\n\n\n\nLouis Ashe-Jepson\n\n\nMob: +44 (0) 7747 515 393\n\n\n\n\n\n\n\n\n \nAbout Inspiration Healthcare Group plc\n \nInspiration Healthcare Group plc (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.\n \nThe Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.\n \...